Enterprise Therapeutics Appoints Dr Renu Gupta as CMO and Dr Janet Hammond as Non-Executive Director
Position
Director
Company
Enterprise Therapeutics Ltd
BrightonBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Enterprise Therapeutics announced the appointment of Dr Renu Gupta as CMO and Dr Janet Hammond as a Non-Executive Director. Dr Gupta brings over 20 years of experience in the biopharmaceutical industry, while Dr Hammond has over 20 years’ experience in the pharmaceutical industry, overseeing the development and successful approval of several drugs.
Quick answer
Enterprise Therapeutics Appoints Dr Renu Gupta as CMO and Dr Janet Hammond as Non-Executive Director (June 17, 2024). Enterprise Therapeutics Ltd is based in Brighton, England, United Kingdom.
- Who is the new Director at Enterprise Therapeutics Ltd?
- Enterprise Therapeutics Ltd named Janet Hammond Director, announced June 17, 2024.
- What did Enterprise Therapeutics Ltd announce on June 17, 2024?
- Enterprise Therapeutics announced the appointment of Dr Renu Gupta as CMO and Dr Janet Hammond as a Non-Executive Director. Dr Gupta brings over 20 years of experience in the biopharmaceutical industry, while Dr Hammond has over 20 years’ experience in the pharmaceutical industry, overseeing the development and successful approval of several drugs.
- What does Enterprise Therapeutics Ltd do?
- Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases.
- Where is Enterprise Therapeutics Ltd based?
- Enterprise Therapeutics Ltd is based in Brighton, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- AbbVie Inc. (June 20, 2024), MBX Biosciences, Inc. (June 25, 2024), Contineum Therapeutics (June 3, 2024) and Atossa Therapeutics (July 2, 2024) also announced leadership changes within 45 days of Enterprise Therapeutics Ltd.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie Appoints Roxanne S. Austin as Lead Independent Director (June 20, 2024)
- MBX Biosciences Appoints Salomon (Sam) Azoulay, M.D, as Chief Medical Officer (June 25, 2024)
- Contineum Therapeutics Appoints John Healy as General Counsel & Corporate Secretary (June 3, 2024)
- Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer (July 2, 2024)
- Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D. as Senior Vice President of Medical Affairs (May 30, 2024)
- Alkeus Pharmaceuticals Appoints Eric L. Trachtenberg as Chief Legal Officer (May 29, 2024)
Who to call at Enterprise Therapeutics Ltd, and when
A new leader at Enterprise Therapeutics Ltd brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Enterprise Therapeutics Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Enterprise Therapeutics Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Enterprise Therapeutics Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Enterprise Therapeutics Ltd changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Enterprise Therapeutics Ltd changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.